Exiris is awarded a Eurotransbio grant in the context of the ColCab consortium (1.5 M€), to discover new cancer stem cell targets and specific mAbs.
Jan
01
Exiris is awarded a Eurotransbio grant in the context of the ColCab consortium (1.5 M€), to discover new cancer stem cell targets and specific mAbs.
Comments are closed.